SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
← All insights
Analyst Upgrades

4 Top Analysts Upgrade CG Oncology, Inc. Price Targets

4 raises inside 7 days

Last updated: November 20, 2026, 8:25 AM ET· CGON profile

Price targets move in herds, which is exactly why a cluster of raises inside a week is worth separating from a single analyst changing their mind. Here is who moved, by how much, and what the people inside the company were doing at the same time.

The data
AnalystNew targetUpside %
Brad Canino$120.00+46.5%
Brian Cheng$113.00+38%
Greg Renza$100.00+22.1%
Leonid Timashev$97.00+18.4%
Source: Published analyst price targets · InsiderBuying.com

The upgrades

4 analysts raised targets on CGON in the last 7 days, the most recent on November 19th, 2026.

The new targets run from $97.00 to $120.00, against a share price of $81.90.

A target is a published opinion with a number attached. It commits the analyst to something checkable, which is more than most commentary does.

The data
AnalystNew targetUpside %
Brad Canino$120.00+46.5%
Brian Cheng$113.00+38%
Greg Renza$100.00+22.1%
Leonid Timashev$97.00+18.4%
Source: Published analyst price targets · InsiderBuying.com

What insiders did over the same period

Over six months the filings record $27.48 million of open-market buying and $2.86 million of selling by company insiders.

Insiders were net buyers, which puts their money on the same side as the upgrades.

Analysts publish opinions; insiders publish transactions. When the two disagree it is worth knowing which one has money behind it.

The filings
  • November 18th, 2026buyKuan Arthur · CEO$2.37 millionForm 4
  • November 18th, 2026buyKalofonos Isabel · Other$299,161Form 4
  • November 16th, 2026sellPOST LEONARD E · Director$92,000Form 4
  • October 15th, 2026sellPOST LEONARD E · Director$30,825Form 4
  • October 15th, 2026sellPOST LEONARD E · Director$31,240Form 4
  • September 15th, 2026sellPOST LEONARD E · Director$72,980Form 4
  • August 14th, 2026sellPOST LEONARD E · Director$74,540Form 4
  • July 15th, 2026sellPOST LEONARD E · Director$71,170Form 4
  • July 10th, 2026sellMulay James · Director$1.82 millionForm 4
  • June 25th, 2026buyLiu Brian Guan-Chyun · Director$24.81 millionForm 4
  • June 24th, 2026sellPOST LEONARD E · Director$350,000Form 4
  • June 22nd, 2026sellPOST LEONARD E · Director$325,000Form 4
Source: SEC Form 4 filings · InsiderBuying.com
The filings
  • November 18th, 2026buyKuan Arthur · CEO$2.37 millionForm 4
  • November 18th, 2026buyKalofonos Isabel · Other$299,161Form 4
  • November 16th, 2026sellPOST LEONARD E · Director$92,000Form 4
  • October 15th, 2026sellPOST LEONARD E · Director$30,825Form 4
  • October 15th, 2026sellPOST LEONARD E · Director$31,240Form 4
  • September 15th, 2026sellPOST LEONARD E · Director$72,980Form 4
  • August 14th, 2026sellPOST LEONARD E · Director$74,540Form 4
  • July 15th, 2026sellPOST LEONARD E · Director$71,170Form 4
  • July 10th, 2026sellMulay James · Director$1.82 millionForm 4
  • June 25th, 2026buyLiu Brian Guan-Chyun · Director$24.81 millionForm 4
  • June 24th, 2026sellPOST LEONARD E · Director$350,000Form 4
  • June 22nd, 2026sellPOST LEONARD E · Director$325,000Form 4
Source: SEC Form 4 filings · InsiderBuying.com

The bottom line

A wave of raises tells you sentiment moved. The filings tell you whether anyone inside the building agreed. Not investment advice. Summarized from public SEC Form 4 and congressional disclosure data and analyst ratings data.